AZOLE RESISTANCE IN ASPERGILLUS: AN EMERGING PROBLEM?

REFERENCES

• Enoch DA, Ludlam HA, Brown NM. Invasive fungal infections: a review of epide-miology and management options. J Med Micro biol 2006; 55: 809–818.
   PubMed Web of Science ®Google Scholar
• Maschmeyer G, Haas A, Comely OA. Invasive aspergillosis: epidemiology, diag-nosis and management in immunocompromised patients. Drugs 2007; 67(11): 1567–1601.
   PubMed Web of Science ®Google Scholar
• Segal BH. Aspergillosis. N Engl J Med 2009; 360(18): 1870–1884.
   PubMed Web of Science ®Google Scholar
• Lass-Flärl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009; 52(3): 197–205.
   Web of Science ®Google Scholar
• Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000; 30(4): 696–709.
   PubMed Web of Science ®Google Scholar
• Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005; 43 (Suppl 1): 5207–S238.
   Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW, et al. Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46(3): 327–360.
   PubMed Web of Science ®Google Scholar
• Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32(3): 358–366.
   PubMed Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007; 45(2): 205–216.
   PubMed Web of Science ®Google Scholar
• Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol 2011; 49 (Suppl 1): 57–512.
   Google Scholar
• Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J2007; 30(4): 782–800.
   Web of Science ®Google Scholar
• Mezger M, Einsele H, Loeffler J. Genetic susceptibility to infections with Asper-gillus fumigatus. Crit Rev Microbiol 2010; 36(2): 168–177.
   PubMed Web of Science ®Google Scholar
• von Eiff M, Roos N, Schulten R, et al. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62(6): 341–347.
   PubMed Web of Science ®Google Scholar
• Ferreira ME, Colombo AL, Paulsen I, et al. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus. Med Mycol. 200; 43 (Suppl 1): S313–5319.
   Google Scholar
• Bueid A, Howard SJ, Moore CB, et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother 2010; 65(10): 2116–2118.
   PubMed Web of Science ®Google Scholar
• Jeurissen A, Cooreman S, Van Kerckhoven W, et al. Invasive pulmonary aspergil-losis due to a multi-azole resistant Aspergillus fumigatus. Acta Clinica Belgica 2011, in press.
   Web of Science ®Google Scholar
• Howard SJ, Cerar D, Anderson MJ, et al. Frequency and evolution of Azole resis-tance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15(7): 1068–1076.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Mellado E, Melchers WJ. Multiple-triazole-resistant aspergillosis. N Engl J Med 2007; 356(14): 1481–1483.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Howard SJ, Melchers WJ, Denning DW. Azole-resistance in Aspergil-lus: proposed nomenclature and breakpoints. Drug Resist Updat 2009; 12(6): 141–147.
   Web of Science ®Google Scholar
• van der Linden JW, Warns A, van der Meer JW, Bresters D, Melchers WJ, Ver-weij PE. Azole-resistant invasive aspergillosis. Ned Tijdschr Geneeskd 2009; 153: A765.
   Google Scholar
• Hong SB, Shin HD, Hong J, et al. New taxa of Neosartorya and Aspergillus in Aspergillus section Fumigati. Antonie Van Leeuwenhoek 2008; 93(1-2): 87–98.
   Web of Science ®Google Scholar
• Balajee SA, Kano R, Baddley JW, et al. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009; 47(10): 3138–3141.
   PubMed Web of Science ®Google Scholar
• Van Der Linden JW, Warns A, Verweij PE. Aspergillus species intrinsically resis-tant to antifungal agents. Med Mycol 2011; 49 (Suppl 1): S82–589.
   PubMedGoogle Scholar
• Symoens F, Haase G, Pihet M, et al. Unusual Aspergillus species in patients with cystic fibrosis. Med Mycol 2010; 48 (Suppl 1): 510–S16.
   Google Scholar
• Vinh DC, Shea YR, Jones PA, Freeman AF, Zelazny A, Holland SM. Chronic inva-sive aspergillosis caused by Aspergillus viridinutans. Emerg Infect Dis 2009; 15(8): 1292–1294.
   Web of Science ®Google Scholar
• Coelho D, Silva S, Vale-Silva LS, et al. Aspergillus viridinutans: an agent of adult chronic invasive aspergillosis. Med Mycol 2011; Feb 7 [Epub ahead of print].
   Web of Science ®Google Scholar
• Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis (2005); 5(10): 609–622.
   PubMed Web of Science ®Google Scholar
• Torres HA, Rivero GA, Lewis RE, Hachem R, Raad II, Kontoyiannis DP. Aspergil-losis caused by non-fumigatus Aspergillus species: risk factors and in vitro sus-ceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis 2003; 46(1): 25–28.
   Google Scholar
• Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DP. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Micro-biol Infect Dis 2005; 52(1): 15–20.
   PubMed Web of Science ®Google Scholar
• Chamilos G, Kontoyiannis DP. Update on antifungal drug resistance mecha-nisms of Aspergillus fumigatus. Drug Resist Updat 2005; 8(6): 344–358.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Diekema DJ, Fothergill A, et al. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). J Clin Microbial 2010; 48(9): 3251–3257.
   PubMed Web of Science ®Google Scholar
• Hachem RY, Kontoyiannis DP, Boktour MR, Afif C, Cooksley C, Bodey GP, Chatzinikolaou I, Perego C, Kantarjian HM, Raad II. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hema-tologic malignancies. Cancer 2004; 101(7): 1594–600.
   Web of Science ®Google Scholar
• Rijping MJ, Gerlach S, Fischer G, et al. Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study. J Hosp Infect 2011; Mar 24 [Epub ahead of print].
   Web of Science ®Google Scholar
• Mortensen KL, Mellado E, Lass-Flörl C, Rodriguez-Tudela JL, Johansen HK, Aren-drup MC. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother 2010; 54(11): 4545–4549.
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C, Rath P, Niederwieser D, et al. Aspergillus terreus infections in hae-matological malignancies: molecular epidemiology suggests association with in-hospital plants. J Hosp Infect 2000; 46(1): 31–35.
   Web of Science ®Google Scholar
• Lass-Flörl C, Kofler G, Kropshofer G, et al. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergil-losis. JAntimicrob Chemother 1998; 42(4): 497–502.
   Web of Science ®Google Scholar
• Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 2011; 49 (Suppl 1): 590–595.
   Google Scholar
• Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 2009; 9(12): 789–795.
   PubMed Web of Science ®Google Scholar
• Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE. Emergence of azole resistance in Aspergil-lus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5(11): e219.
   PubMed Web of Science ®Google Scholar
• Lagrou K, De Vleeschouwer J, Meerseman W, et al. Triazole resistance among 229 clinical Aspergillus fumigatus isolates. Proceedings of the 3rd Advances Against Aspergillosis Meeting, Miami, FL, USA; Jan 16–19, 2008. Abstract 33.
   Google Scholar
• Mellado E, Garcia-Effron G, Alcazar-Fuoli L, et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 2007; 51(6): 1897–904.
   PubMed Web of Science ®Google Scholar
• Rajendran R, Mowat E, McCulloch E, et al. Azole resistance of Aspergillus fumi-gatus biofilms is partly associated with efflux pump activity. Antimicrob Agents Chem other 2011; 55(5): 2092–2097.
   PubMed Web of Science ®Google Scholar
• Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 2011; 49 Suppl 1:S90–S95.
   PubMedGoogle Scholar
• Alanio A, Sitterlé E, Liance M, Farrugia C, Foulet F, Botterel F, Hicheri Y, Cordonnier C, Costa JM, Bretagne S. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. J Antimicrob Chem other 2011; 66(2): 371–374.
   PubMed Web of Science ®Google Scholar
• Andaluz N, Zuccarello M. Multidrug-resistant, progressive, invasive diffuse spi-nal aspergillosis: case report and review of the literature. J Neurosurg Sci 2008; 52(2): 49–53.
   Web of Science ®Google Scholar
• Arendrup MC, Mavridou E, Mortensen KL, Snelders E, Frimodt-Moller N, Khan H, Melchers WJ, Verweij PE. Development of azole resistance in Aspergillus fumig-atus during azole therapy associated with change in virulence. PLoS One 2010; 5(4): e10080.
   PubMed Web of Science ®Google Scholar
• Kuipers S, Brüggemann RJ, de Sévaux RG, et al. Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole. Antimicrob Agents Chem other 2011; Apr 18 [Epub ahead of print].
   Web of Science ®Google Scholar
• Howard SJ, Webster I, Moore CB, Gardiner RE, Park S, Perlin DS, Denning DW. Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents 2006; 28(5): 450–453.
   PubMed Web of Science ®Google Scholar
• Denning DW, Park S, Lass-Florl C, Fraczek MG, Kirwan M, Gore R, Smith J, Bueid A, Moore CB, Bowyer P. Perlin DS. High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52(9): 1123–1129.
   PubMed Web of Science ®Google Scholar